PUBLIC CONTRACT · 2021
4160114/2021 - Med. Bevacizumab 400 mg (25 mg/ml AMP 16 ml) sol inj_bevacizumab 100 mg (25 mg/ml AMP 4 ml)
- Contract value
- €22,500.25
- Signed on
- 18 March 2021
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7575964PUBLISHED SUBJECT
4160114/2021 - MED. BEVACIZUMAB 400 MG (25 MG/ML AMP 16 ML) SOL INJ_BEVACIZUMAB 100 MG (25 MG/ML AMP 4 ML)
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- RoCHE · Tax ID 500233810
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €22,500.25
- Procedure base price
- €22,500.25
- Total effective price
- €22,500.25
- Publication date
- 19 March 2021
- Award date
- 18 March 2021
- Signing date
- 18 March 2021
- Performance period
- 30 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5228267
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.